PKM and acute promyelocytic leukemia: Mucin 1‐C [61] and death‐associated protein kinase (DAPK) [62] activate, while promyelocytic leukemia (PML) tumor‐suppressor protein [63] reduces the pyruvate kinase activity of PKM2 via protein–protein interaction.